These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10440875)

  • 41. Chromosome 8 genetic analysis and phenotypic characterization of 21 ovarian cancer cell lines.
    Arnold JM; Woollatt E; Chenevix-Trench G
    Cancer Genet Cytogenet; 2002 Dec; 139(2):109-14. PubMed ID: 12550770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of heterozygosity on 8p in prostate cancer implicates a role for dematin in tumor progression.
    Lutchman M; Pack S; Kim AC; Azim A; Emmert-Buck M; van Huffel C; Zhuang Z; Chishti AH
    Cancer Genet Cytogenet; 1999 Nov; 115(1):65-9. PubMed ID: 10565303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.
    Weber RG; Pietsch T; von Schweinitz D; Lichter P
    Am J Pathol; 2000 Aug; 157(2):571-8. PubMed ID: 10934159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization.
    van Duin M; van Marion R; Watson JE; Paris PL; Lapuk A; Brown N; Oseroff VV; Albertson DG; Pinkel D; de Jong P; Nacheva EP; Dinjens W; van Dekken H; Collins C
    Cytometry A; 2005; 63(1):10-9. PubMed ID: 15619731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.
    Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C
    Int J Cancer; 2001 Jun; 92(6):824-31. PubMed ID: 11351302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.
    van Duin M; van Marion R; Vissers K; Watson JE; van Weerden WM; Schröder FH; Hop WC; van der Kwast TH; Collins C; van Dekken H
    Genes Chromosomes Cancer; 2005 Dec; 44(4):438-49. PubMed ID: 16130124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.
    Pan Y; Kytölä S; Farnebo F; Wang N; Lui WO; Nupponen N; Isola J; Visakorpi T; Bergerheim US; Larsson C
    Cytogenet Cell Genet; 1999; 87(3-4):225-32. PubMed ID: 10702678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization.
    Maljaei SH; Brito-Babapulle V; Hiorns LR; Catovsky D
    Cancer Genet Cytogenet; 1998 Jun; 103(2):110-6. PubMed ID: 9614908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the human myeloid leukemia-derived cell line GF-D8 by multiplex fluorescence in situ hybridization, subtelomeric probes, and comparative genomic hybridization.
    Tosi S; Giudici G; Rambaldi A; Scherer SW; Bray-Ward P; Dirscherl L; Biondi A; Kearney L
    Genes Chromosomes Cancer; 1999 Mar; 24(3):213-21. PubMed ID: 10451701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deletion of chromosomal region 6q14-16 in prostate cancer.
    Verhagen PC; Hermans KG; Brok MO; van Weerden WM; Tilanus MG; de Weger RA; Boon TA; Trapman J
    Int J Cancer; 2002 Nov; 102(2):142-7. PubMed ID: 12385009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular cytogenetic analysis of oral squamous cell carcinomas by comparative genomic hybridization, spectral karyotyping, and fluorescence in situ hybridization.
    Uchida K; Oga A; Okafuji M; Mihara M; Kawauchi S; Furuya T; Chochi Y; Ueyama Y; Sasaki K
    Cancer Genet Cytogenet; 2006 Jun; 167(2):109-16. PubMed ID: 16737909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allelic loss detected on chromosomes 8, 10, and 17 by fluorescence in situ hybridization using single-copy P1 probes on isolated nuclei from paraffin-embedded prostate tumors.
    Deubler DA; Williams BJ; Zhu XL; Steele MR; Rohr LR; Jensen JC; Stephenson RA; Changus JE; Miller GJ; Becich MJ; Brothman AR
    Am J Pathol; 1997 Mar; 150(3):841-50. PubMed ID: 9060822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fetoplacental discrepancy involving structural abnormalities of chromosome 8 detected by prenatal diagnosis.
    Soler A; Sánchez A; Carrió A; Badenas C; Milà M; Borrell A
    Prenat Diagn; 2003 Apr; 23(4):319-22. PubMed ID: 12673638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural alterations of chromosome 5 in twelve human prostate cancer cell lines.
    Ozen M; Navone NM; Multani AS; Troncoso P; Logothetis CJ; Chung LW; von Eschenbach AC; Pathak S
    Cancer Genet Cytogenet; 1998 Oct; 106(2):105-9. PubMed ID: 9797773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Losses of chromosome arms 4q, 8p, 13q and gain of 8q are correlated with increasing chromosomal instability in hepatocellular carcinoma.
    Hertz S; Rothämel T; Skawran B; Giere C; Steinemann D; Flemming P; Becker T; Flik J; Wiese B; Soudah B; Kreipe H; Schlegelberger B; Wilkens L
    Pathobiology; 2008; 75(5):312-22. PubMed ID: 18931534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytogenetic abnormalities are frequent in uncultured prostate cancer cells.
    Webb HD; Hawkins AL; Griffin CA
    Cancer Genet Cytogenet; 1996 Jun; 88(2):126-32. PubMed ID: 8640720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gain in chromosome 8q correlates with early progression in hormonal treated prostate cancer.
    Steiner T; Junker K; Burkhardt F; Braunsdorf A; Janitzky V; Schubert J
    Eur Urol; 2002 Feb; 41(2):167-71. PubMed ID: 12074404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.
    Presti JC; Wilhelm M; Reuter V; Russo P; Motzer R; Waldman F
    J Urol; 2002 Mar; 167(3):1464-8. PubMed ID: 11832771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.